1. Home
  2. IMUX vs AIRE Comparison

IMUX vs AIRE Comparison

Compare IMUX & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • AIRE
  • Stock Information
  • Founded
  • IMUX 2016
  • AIRE 2021
  • Country
  • IMUX United States
  • AIRE United States
  • Employees
  • IMUX N/A
  • AIRE N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • AIRE
  • Sector
  • IMUX Health Care
  • AIRE
  • Exchange
  • IMUX Nasdaq
  • AIRE Nasdaq
  • Market Cap
  • IMUX 107.3M
  • AIRE 86.1M
  • IPO Year
  • IMUX N/A
  • AIRE N/A
  • Fundamental
  • Price
  • IMUX $0.68
  • AIRE $0.46
  • Analyst Decision
  • IMUX Strong Buy
  • AIRE Strong Buy
  • Analyst Count
  • IMUX 6
  • AIRE 1
  • Target Price
  • IMUX $11.60
  • AIRE $1.25
  • AVG Volume (30 Days)
  • IMUX 1.4M
  • AIRE 2.1M
  • Earning Date
  • IMUX 05-15-2025
  • AIRE 05-16-2025
  • Dividend Yield
  • IMUX N/A
  • AIRE N/A
  • EPS Growth
  • IMUX N/A
  • AIRE N/A
  • EPS
  • IMUX N/A
  • AIRE N/A
  • Revenue
  • IMUX N/A
  • AIRE $1,853,629.00
  • Revenue This Year
  • IMUX N/A
  • AIRE $206.83
  • Revenue Next Year
  • IMUX N/A
  • AIRE $158.08
  • P/E Ratio
  • IMUX N/A
  • AIRE N/A
  • Revenue Growth
  • IMUX N/A
  • AIRE 1925.60
  • 52 Week Low
  • IMUX $0.56
  • AIRE $0.45
  • 52 Week High
  • IMUX $2.11
  • AIRE $4.49
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 27.13
  • AIRE 30.76
  • Support Level
  • IMUX $0.56
  • AIRE $0.45
  • Resistance Level
  • IMUX $0.95
  • AIRE $0.50
  • Average True Range (ATR)
  • IMUX 0.07
  • AIRE 0.05
  • MACD
  • IMUX -0.03
  • AIRE 0.00
  • Stochastic Oscillator
  • IMUX 22.66
  • AIRE 2.96

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.

Share on Social Networks: